Systematic Financial Management LP Supernus Pharmaceuticals, Inc. Transaction History
Systematic Financial Management LP
- $3.78 Billion
- Q4 2024
A detailed history of Systematic Financial Management LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Systematic Financial Management LP holds 113,500 shares of SUPN stock, worth $3.59 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
113,500
Previous 28,185
302.7%
Holding current value
$3.59 Million
Previous $878,000
367.43%
% of portfolio
0.11%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding SUPN
# of Institutions
304Shares Held
60.7MCall Options Held
22.3KPut Options Held
6K-
Black Rock Inc. New York, NY10.4MShares$328 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$194 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.84MShares$153 Million2.47% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$91 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$83.1 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.69B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...